ConductScience.org, home

Paper2467807

The late effects of cis-platinum on renal function.

Hamilton CR and 2 others. Eur J Cancer Clin Oncol, 1989. Cited by 61 papers, by iCite.

Cite this record

ConductScience Library. The late effects of cis-platinum on renal function. Papers, record 2467807. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/2467807

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
The late effects of cis-platinum on renal function.
PubMed
Journal
Eur J Cancer Clin Oncol
PubMed
Year
1989
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
61
iCite
Relative citation ratio, by iCite
2.87
iCite
Revised in PubMed
2019-09-08
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Hamilton CRC R
2Bliss JMJ M
3Horwich AA

Source PubMed

Download CSV of authors

Topics14

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
CisplatinMajor topic
KidneyMajor topic
Testicular NeoplasmsMajor topic
Adolescent
Adult
Antineoplastic Combined Chemotherapy Protocols
Bleomycin
Etoposide
Glomerular Filtration Rate
Humans
Male
Middle Aged
Teratoma
Time Factors

Source PubMed

Download CSV of topics

Cited by16

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 61 citations.

PMIDTitleJournalYearIn PapersSource
37958709
Efficacy of Mesenchymal-Stromal-Cell-Derived Extracellular Vesicles in Ameliorating Cisplatin Nephrotoxicity, as Modeled Using Three-Dimensional, Gravity-Driven, Two-Layer Tubule-on-a-Chip (3D-MOTIVE Chip).
Int J Mol Sci2023https://conductscience.org/library/papers/37958709PubMed
26244343
Liquid Chromatography Electrospray Ionization Tandem Mass Spectrometric (LC/ESI-MS/MS) Study for the Identification and Characterization of In Vivo Metabolites of Cisplatin in Rat Kidney Cancer Tissues: Online Hydrogen/Deuterium (H/D) Exchange Study.
PLoS One2015https://conductscience.org/library/papers/26244343PubMed
21847130Accelerated BEP: a phase I trial of dose-dense BEP for intermediate and poor prognosis metastatic germ cell tumour.Br J Cancer2011https://conductscience.org/library/papers/21847130PubMed
17848741Long-term complications of platinum-based chemotherapy in testicular cancer survivors.Med Oncol2007https://conductscience.org/library/papers/17848741PubMed
12373594Platinum drugs in the treatment of non-small-cell lung cancer.Br J Cancer2002https://conductscience.org/library/papers/12373594PubMed
11696449Gamma-glutamyl transpeptidase-deficient mice are resistant to the nephrotoxic effects of cisplatin.Am J Pathol2001https://conductscience.org/library/papers/11696449PubMed
10958599A randomized trial comparing the nephrotoxicity of cisplatin/ifosfamide-based combination chemotherapy with or without amifostine in patients with solid tumors.Invest New Drugs2000https://conductscience.org/library/papers/10958599PubMed
8706780Acute tubular necrosis following high-dose cyclosporine A therapy.Eur J Clin Pharmacol1996https://conductscience.org/library/papers/8706780PubMed
8573296Comparative adverse effect profiles of platinum drugs.Drug Saf1995https://conductscience.org/library/papers/8573296PubMed
2265457Cisplatin-induced reductions in renal functional reserve uncovered by unilateral nephrectomy: an experimental study in the pig.Cancer Chemother Pharmacol1990https://conductscience.org/library/papers/2265457PubMed
2173944Renal function related to different treatment modalities for malignant germ cell tumours.Br J Cancer1990https://conductscience.org/library/papers/2173944PubMed
2171622Long-term sequelae of treatment for testicular germ cell tumours.Br J Cancer1990https://conductscience.org/library/papers/2171622PubMed
1850612The effect of carboplatin on renal function in patients with metastatic germ cell tumours.Br J Cancer1991https://conductscience.org/library/papers/1850612PubMed
1742846The relative nephrotoxicity of cisplatin, cis-[Pt(NH3)2(guanosine)2]2+, and the hydrolysis product of cisplatin in the rat.Cancer Chemother Pharmacol1991https://conductscience.org/library/papers/1742846PubMed
1537078Long-term studies of cisplatin-induced reductions in porcine renal functional reserve.Cancer Chemother Pharmacol1992https://conductscience.org/library/papers/1537078PubMed
1323992Cisplatin therapy in infants: short and long-term morbidity.Br J Cancer Suppl1992https://conductscience.org/library/papers/1323992PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/2467807

GET https://conductscience.org/api/papers/v1/2467807/authors